Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Osmotica Pharmaceutical

Osmotica Pharmaceutical?uq=UG6efJS6
1986 FOUNDED
IPO REG STATUS
401-500 EMPLOYEES
IPO LATEST DEAL TYPE (Announced)
4 FINANCING ROUNDS
Description

Developer of branded and generic pharmaceutical products. The company develops both specialty and generic pharmaceutical products, neurology-based therapeutic drugs along with a portfolio of products in various stages of development focused on the treatment of movement disorders and central nervous system, using osmotic and proprietary drug delivery technology and extensive research & development, providing healthcare industry with successful commercial drugs that address the growing needs of global patient population.

Ownership Status
In IPO Registration
Financing Status
Private Equity-Backed
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Drug Discovery
Primary Office
  • 895 Sawyer Road
  • Marietta, GA 30062
  • United States

+1 (770) 000-0000

Osmotica Pharmaceutical Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Osmotica Pharmaceutical‘s full profile, request access.

Request full access to PitchBook

Osmotica Pharmaceutical Executive Team (4)

Name Title Board
Seat
Contact
Info
Andrew Einhorn Chief Financial Officer
Brian Markison Chief Executive Officer

2 Former Executives

You’re viewing 2 of 4 executives. Get the full list »